HC Wainwright Analyst Recommendations & Stock Picks

Name: Community Performance Rating
Item: HC Wainwright
Rating: 0
Author: MarketBeat

View the latest stock recommendations issued by analysts at HC Wainwright. This page tracks publicly reported analyst upgrades and downgrades, buy/hold/sell ratings, and price target changes for publicly traded companies. All data is compiled from credible public sources and updated regularly to reflect new insights from HC Wainwright's equity research team. MarketBeat is not affiliated with or endorsed by HC Wainwright.

36 Analysts
Updated 8/11/2026

Brokerage Ranking: Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating MarketBeat
Average Return: 00.00% 12-Month ROI
Total Ratings: 2,088 Last 12 Months
Buy Ratings: 1,923 Last 12 Months
Sell Ratings: 12 Last 12 Months
Companies Covered: 644 Last 12 Months

Company	Current Price	Report Date	Analyst	Action	Price Target	Rating	Details
ACHR Archer Aviation	$6.81 +8.7%	8/11/2026		Reiterated Rating		Buy	View details for HC Wainwright rating of Archer Aviation (NYSE:ACHR) on 8/11/2026
SRFM Surf Air Mobility	$0.80 -6.3%	8/11/2026		Reiterated Rating		Buy	View details for HC Wainwright rating of Surf Air Mobility (NYSE:SRFM) on 8/11/2026
AGEN Agenus	$6.83 -2.4%	8/11/2026	Emily Bodnar Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	$30.00 ➝ $25.00	Buy	View details for HC Wainwright rating of Agenus (NASDAQ:AGEN) on 8/11/2026
ETON Eton Pharmaceuticals	$42.05 -3.7%	8/11/2026	Swayampakula Ramakanth Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Price Target	$57.00 ➝ $65.00	Buy	View details for HC Wainwright rating of Eton Pharmaceuticals (NASDAQ:ETON) on 8/11/2026
NKTX Nkarta	$2.33 -5.3%	8/11/2026	Emily Bodnar Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Lower Price Target	$14.00	Buy	View details for HC Wainwright rating of Nkarta (NASDAQ:NKTX) on 8/11/2026
OLMA Olema Pharmaceuticals	$10.43 -12.6%	8/11/2026	Emily Bodnar Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Lower Price Target	$38.00 ➝ $36.00	Buy	View details for HC Wainwright rating of Olema Pharmaceuticals (NASDAQ:OLMA) on 8/11/2026
HRTX Heron Therapeutics	$0.32 -3.3%	8/11/2026	Brandon Folkes Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Downgrade		Buy ➝ Neutral	View details for HC Wainwright rating of Heron Therapeutics (NASDAQ:HRTX) on 8/11/2026
RIOT Riot Platforms	$20.24 +4.3%	8/11/2026	Mike Colonnese Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Price Target	$25.00 ➝ $40.00	Buy	View details for HC Wainwright rating of Riot Platforms (NASDAQ:RIOT) on 8/11/2026
ASST Strive	$12.62 +1.4%	8/11/2026	Mike Colonnese Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Lower Price Target	$37.00 ➝ $36.00	Buy	View details for HC Wainwright rating of Strive (NASDAQ:ASST) on 8/11/2026
AURA Aura Biosciences	$8.04 +4.4%	8/11/2026	Andres Y. Maldonado Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Lower Price Target	$24.00 ➝ $18.00	Buy	View details for HC Wainwright rating of Aura Biosciences (NASDAQ:AURA) on 8/11/2026
Get the Latest News and Ratings for Your Stocks Enter your email address below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter.
COAG Hemab Therapeutics	$51.74 +3.7%	8/11/2026	Emily Bodnar Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Price Target	$52.00 ➝ $60.00	Buy	View details for HC Wainwright rating of Hemab Therapeutics (NASDAQ:COAG) on 8/11/2026
DMAC DiaMedica Therapeutics	$6.87 +3.3%	8/11/2026	Matthew Caufield Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	$12.00	Buy	View details for HC Wainwright rating of DiaMedica Therapeutics (NASDAQ:DMAC) on 8/11/2026
DRTS Alpha Tau Medical	$14.27 +4.9%	8/11/2026	Yi Chen Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Price Target	$15.00 ➝ $16.00	Buy	View details for HC Wainwright rating of Alpha Tau Medical (NASDAQ:DRTS) on 8/11/2026
FTH Sensei Biotherapeutics	$30.00 +5.0%	8/11/2026	Patrick R. Trucchio Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	$60.00	Buy	View details for HC Wainwright rating of Sensei Biotherapeutics (NASDAQ:FTH) on 8/11/2026
PLUG Plug Power	$2.22 +5.2%	8/11/2026	Amit Dayal Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	$7.00	Buy	View details for HC Wainwright rating of Plug Power (NASDAQ:PLUG) on 8/11/2026
STTK Shattuck Labs	$7.18 +0.6%	8/11/2026	Joseph Pantginis Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Lower Price Target	$18.00 ➝ $14.00	Buy	View details for HC Wainwright rating of Shattuck Labs (NASDAQ:STTK) on 8/11/2026
URG Ur Energy	$1.39 -2.1%	8/11/2026	Heiko F. Ihle Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Lower Price Target	$2.30 ➝ $2.20	Buy	View details for HC Wainwright rating of Ur Energy (NYSEAMERICAN:URG) on 8/11/2026
IPHA Innate Pharma	$2.15 -3.2%	8/10/2026	Swayampakula Ramakanth Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Price Target	$5.00 ➝ $7.00	Buy	View details for HC Wainwright rating of Innate Pharma (NASDAQ:IPHA) on 8/10/2026
NRXP NRx Pharmaceuticals	$3.40 +1.5%	8/10/2026	Patrick R. Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating		Buy	View details for HC Wainwright rating of NRx Pharmaceuticals (NASDAQ:NRXP) on 8/10/2026
ALGS Aligos Therapeutics	$7.28 -4.8%	8/10/2026		Reiterated Rating		Buy	View details for HC Wainwright rating of Aligos Therapeutics (NASDAQ:ALGS) on 8/10/2026
RGNX REGENXBIO	$10.65 +2.2%	8/10/2026	Yi Chen Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Lower Price Target	$26.00 ➝ $23.00	Buy	View details for HC Wainwright rating of REGENXBIO (NASDAQ:RGNX) on 8/10/2026
VNDA Vanda Pharmaceuticals	$4.93 -1.8%	8/10/2026	Raghuram Selvaraju Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Lower Price Target	$21.00 ➝ $20.00	Buy	View details for HC Wainwright rating of Vanda Pharmaceuticals (NASDAQ:VNDA) on 8/10/2026
GHRS GH Research	$29.08 -1.5%	8/10/2026	Patrick R. Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating		Buy	View details for HC Wainwright rating of GH Research (NASDAQ:GHRS) on 8/10/2026
VIR Vir Biotechnology	$8.93 +0.4%	8/10/2026		Reiterated Rating		Buy	View details for HC Wainwright rating of Vir Biotechnology (NASDAQ:VIR) on 8/10/2026
BEAM Beam Therapeutics	$26.85 -1.6%	8/10/2026	Patrick R. Trucchio Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating		Buy	View details for HC Wainwright rating of Beam Therapeutics (NASDAQ:BEAM) on 8/10/2026
SRRK Scholar Rock	$52.07 +0.3%	8/10/2026	Andres Y. Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	$65.00	Buy	View details for HC Wainwright rating of Scholar Rock (NASDAQ:SRRK) on 8/10/2026
XENE Xenon Pharmaceuticals	$63.22 -1.6%	8/10/2026		Reiterated Rating	$74.00	Buy	View details for HC Wainwright rating of Xenon Pharmaceuticals (NASDAQ:XENE) on 8/10/2026
INSM Insmed	$132.57 -1.6%	8/10/2026	Andrew Fein Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating		Buy	View details for HC Wainwright rating of Insmed (NASDAQ:INSM) on 8/10/2026
ORIC Oric Pharmaceuticals	$13.73 +0.8%	8/10/2026	Robert Burns Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Price Target	$25.00 ➝ $27.00	Buy	View details for HC Wainwright rating of Oric Pharmaceuticals (NASDAQ:ORIC) on 8/10/2026
IMMX Immix Biopharma	$11.49 +13.4%	8/10/2026	Robert Burns Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Price Target	$20.00 ➝ $25.00	Buy	View details for HC Wainwright rating of Immix Biopharma (NASDAQ:IMMX) on 8/10/2026
EBS Emergent Biosolutions	$4.44 -0.8%	8/10/2026	Raghuram Selvaraju Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Lower Price Target	$12.00 ➝ $10.00	Buy	View details for HC Wainwright rating of Emergent Biosolutions (NYSE:EBS) on 8/10/2026
OKLO Oklo	$47.12 +5.9%	8/10/2026	Sameer Joshi Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	$90.00	Buy	View details for HC Wainwright rating of Oklo (NYSE:OKLO) on 8/10/2026
PRME Prime Medicine	$3.26 +3.5%	8/10/2026	Arthur He Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	$8.00	Buy	View details for HC Wainwright rating of Prime Medicine (NASDAQ:PRME) on 8/10/2026
RARE Ultragenyx Pharmaceutical	$26.96 +0.6%	8/10/2026	Raghuram Selvaraju Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	$50.00	Buy	View details for HC Wainwright rating of Ultragenyx Pharmaceutical (NASDAQ:RARE) on 8/10/2026
SRZN Surrozen	$25.05 -0.2%	8/10/2026	Matthew Caufield Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	$44.00	Buy	View details for HC Wainwright rating of Surrozen (NASDAQ:SRZN) on 8/10/2026
VYGR Voyager Therapeutics	$3.20 +0.9%	8/10/2026	Patrick R. Trucchio Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating		Buy	View details for HC Wainwright rating of Voyager Therapeutics (NASDAQ:VYGR) on 8/10/2026
ROIV Roivant Sciences	$35.25 -1.5%	8/7/2026	Douglas Tsao Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Price Target	$34.00 ➝ $41.00	Buy	View details for HC Wainwright rating of Roivant Sciences (NASDAQ:ROIV) on 8/7/2026
DCTH Delcath Systems	$17.22 +3.3%	8/7/2026	Swayampakula Ramakanth Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	$30.00 ➝ $32.00	Buy	View details for HC Wainwright rating of Delcath Systems (NASDAQ:DCTH) on 8/7/2026
ARDX Ardelyx	$3.94 -1.5%	8/7/2026		Reiterated Rating	$13.00	Buy	View details for HC Wainwright rating of Ardelyx (NASDAQ:ARDX) on 8/7/2026
CMPS Compass Pathways	$13.38 +1.5%	8/7/2026	Patrick R. Trucchio Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Lower Price Target	$70.00 ➝ $65.00	Buy	View details for HC Wainwright rating of Compass Pathways (NASDAQ:CMPS) on 8/7/2026
The $15 Gold Fund That Pays Up to $1,152/Month (Ad) Gold is hitting record highs, but most investors are leaving income on the table. A $15 fund is quietly paying out up to $1,152 a month to regular investors - no mining stocks, no options, no physical metal required. Chief Income Strategist Tim Plaehn calls it a breakthrough strategy that transforms gold's rally into reliable monthly payouts. The next distribution is just days away. Discover the gold income fund before the next payout date
MUX McEwen	$19.16 -0.1%	8/7/2026	Heiko Ihle Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	$29.50 ➝ $28.00	Buy	View details for HC Wainwright rating of McEwen (NYSE:MUX) on 8/7/2026
CLSK Cleanspark	$11.52 -0.6%	8/7/2026		Reiterated Rating		Buy	View details for HC Wainwright rating of Cleanspark (NASDAQ:CLSK) on 8/7/2026
AVTX Avalo Therapeutics	$19.47 -1.5%	8/7/2026	Mitchell S. Kapoor Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Lower Price Target	$35.00 ➝ $30.00	Buy	View details for HC Wainwright rating of Avalo Therapeutics (NASDAQ:AVTX) on 8/7/2026
BLNK Blink Charging	$0.59 -1.4%	8/7/2026	Sameer Joshi Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Lower Price Target	$2.50	Buy	View details for HC Wainwright rating of Blink Charging (NASDAQ:BLNK) on 8/7/2026
BMRN BioMarin Pharmaceutical	$69.55 +1.0%	8/7/2026	Mitchell S. Kapoor Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Price Target	$50.00 ➝ $60.00	Neutral	View details for HC Wainwright rating of BioMarin Pharmaceutical (NASDAQ:BMRN) on 8/7/2026
CRBP Corbus Pharmaceuticals	$9.51 +0.5%	8/7/2026	Andres Y. Maldonado Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Lower Price Target	$40.00 ➝ $35.00	Buy	View details for HC Wainwright rating of Corbus Pharmaceuticals (NASDAQ:CRBP) on 8/7/2026
HALO Halozyme Therapeutics	$102.62	8/7/2026	Mitchell S. Kapoor Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Price Target	$95.00 ➝ $115.00	Buy	View details for HC Wainwright rating of Halozyme Therapeutics (NASDAQ:HALO) on 8/7/2026
LFMD LifeMD	$3.38 -6.6%	8/7/2026	Yi Chen Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Lower Price Target	$10.00 ➝ $9.00	Buy	View details for HC Wainwright rating of LifeMD (NASDAQ:LFMD) on 8/7/2026
RCAT Red Cat	$10.66 +6.6%	8/7/2026	Amit Dayal Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	$20.00	Buy	View details for HC Wainwright rating of Red Cat (NASDAQ:RCAT) on 8/7/2026
BDSX Biodesix	$24.31 -2.2%	8/6/2026	Yi Chen Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	$26.00 ➝ $27.00	Buy	View details for HC Wainwright rating of Biodesix (NASDAQ:BDSX) on 8/6/2026
GROY Gold Royalty	$3.09 +0.3%	8/6/2026	Heiko Ihle Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Lower Price Target	$7.75 ➝ $7.00	Buy	View details for HC Wainwright rating of Gold Royalty (NYSEAMERICAN:GROY) on 8/6/2026
GPN Global Payments	$85.79 -0.4%	8/6/2026		Initiated Coverage		Buy	View details for HC Wainwright rating of Global Payments (NYSE:GPN) on 8/6/2026
AKBA Akebia Therapeutics	$0.87 +2.7%	8/6/2026	Matthew Caufield Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating		Buy	View details for HC Wainwright rating of Akebia Therapeutics (NASDAQ:AKBA) on 8/6/2026
ALTO Alto Ingredients	$4.17 -1.4%	8/6/2026	Amit Dayal Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating		Buy	View details for HC Wainwright rating of Alto Ingredients (NASDAQ:ALTO) on 8/6/2026
ACAD ACADIA Pharmaceuticals	$29.41 +0.1%	8/6/2026		Reiterated Rating		Buy	View details for HC Wainwright rating of ACADIA Pharmaceuticals (NASDAQ:ACAD) on 8/6/2026
JOBY Joby Aviation	$8.42 -4.5%	8/6/2026		Reiterated Rating		Buy	View details for HC Wainwright rating of Joby Aviation (NYSE:JOBY) on 8/6/2026
SMMT Summit Therapeutics	$15.11 +1.6%	8/6/2026	Mitchell S. Kapoor Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating		Neutral	View details for HC Wainwright rating of Summit Therapeutics (NASDAQ:SMMT) on 8/6/2026
OESX Orion Energy Systems	$19.75 +3.1%	8/6/2026		Reiterated Rating	$30.00	Buy	View details for HC Wainwright rating of Orion Energy Systems (NASDAQ:OESX) on 8/6/2026
ARWR Arrowhead Pharmaceuticals	$89.24 +1.0%	8/6/2026	Patrick R. Trucchio Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Price Target	$115.00 ➝ $120.00	Buy	View details for HC Wainwright rating of Arrowhead Pharmaceuticals (NASDAQ:ARWR) on 8/6/2026
CRCL Circle Internet Group	$71.22 +6.2%	8/6/2026	Mike Colonnese Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Lower Price Target	$115.00 ➝ $104.00	Buy	View details for HC Wainwright rating of Circle Internet Group (NYSE:CRCL) on 8/6/2026
DNTH Dianthus Therapeutics	$108.49 -3.0%	8/6/2026	Swayampakula Ramakanth Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Price Target	$130.00 ➝ $158.00	Buy	View details for HC Wainwright rating of Dianthus Therapeutics (NASDAQ:DNTH) on 8/6/2026
EYPT Eyepoint Pharmaceuticals	$13.05 -0.2%	8/6/2026	Yi Chen Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Lower Price Target	$30.00 ➝ $27.00	Buy	View details for HC Wainwright rating of Eyepoint Pharmaceuticals (NASDAQ:EYPT) on 8/6/2026
IMRX Immuneering	$4.80 +6.0%	8/6/2026	Andres Y. Maldonado Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Initiated Coverage	$14.00	Buy	View details for HC Wainwright rating of Immuneering (NASDAQ:IMRX) on 8/6/2026
IRON Disc Medicine	$81.21 +3.7%	8/6/2026	Douglas Tsao Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Price Target	$118.00 ➝ $120.00	Buy	View details for HC Wainwright rating of Disc Medicine (NASDAQ:IRON) on 8/6/2026
LGND Ligand Pharmaceuticals	$288.75 -2.4%	8/6/2026	Joseph Pantginis Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Price Target	$289.00 ➝ $358.00	Buy	View details for HC Wainwright rating of Ligand Pharmaceuticals (NASDAQ:LGND) on 8/6/2026
MIRM Mirum Pharmaceuticals	$98.23 -0.5%	8/6/2026	Swayampakula Ramakanth Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Lower Price Target	$185.00 ➝ $140.00	Buy	View details for HC Wainwright rating of Mirum Pharmaceuticals (NASDAQ:MIRM) on 8/6/2026
RNA Avidity Biosciences	$12.27 +0.2%	8/6/2026	Mitchell S. Kapoor Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Initiated Coverage	$25.00	Buy	View details for HC Wainwright rating of Avidity Biosciences (NASDAQ:RNA) on 8/6/2026
URGN Urogen Pharma	$47.11 +1.7%	8/6/2026	Raghuram Selvaraju Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Price Target	$45.00 ➝ $75.00	Buy	View details for HC Wainwright rating of Urogen Pharma (NASDAQ:URGN) on 8/6/2026
VTVT vTv Therapeutics	$33.04 -3.6%	8/6/2026	Emily Bodnar Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Lower Price Target	$45.00 ➝ $42.00	Buy	View details for HC Wainwright rating of vTv Therapeutics (NASDAQ:VTVT) on 8/6/2026
ZYME Zymeworks	$24.32 +0.7%	8/5/2026	Robert Burns Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Price Target	$46.00 ➝ $51.00	Buy	View details for HC Wainwright rating of Zymeworks (NASDAQ:ZYME) on 8/5/2026
PGEN Precigen	$6.86 -2.0%	8/5/2026	Swayampakula Ramakanth Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Price Target	$14.00 ➝ $18.00	Buy	View details for HC Wainwright rating of Precigen (NASDAQ:PGEN) on 8/5/2026
OCS Oculis	$12.75 -0.1%	8/5/2026	Yi Chen Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	$26.00	Buy	View details for HC Wainwright rating of Oculis (NASDAQ:OCS) on 8/5/2026
SNDX Syndax Pharmaceuticals	$20.29 -0.4%	8/5/2026	Andres Y. Maldonado Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Lower Price Target	$40.00 ➝ $38.00	Buy	View details for HC Wainwright rating of Syndax Pharmaceuticals (NASDAQ:SNDX) on 8/5/2026
SOPH SOPHiA GENETICS	$7.61 -0.8%	8/5/2026	Swayampakula Ramakanth Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Price Target	$12.00 ➝ $14.00	Buy	View details for HC Wainwright rating of SOPHiA GENETICS (NASDAQ:SOPH) on 8/5/2026
TYGO Tigo Energy	$1.25 +5.9%	8/5/2026	Amit Dayal Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Lower Price Target	$6.00 ➝ $3.50	Buy	View details for HC Wainwright rating of Tigo Energy (NASDAQ:TYGO) on 8/5/2026
CGEN Compugen	$2.40 +2.6%	8/4/2026		Reiterated Rating		Buy	View details for HC Wainwright rating of Compugen (NASDAQ:CGEN) on 8/4/2026
KROS Keros Therapeutics	$10.64 -0.5%	8/4/2026		Reiterated Rating	$20.00	Buy	View details for HC Wainwright rating of Keros Therapeutics (NASDAQ:KROS) on 8/4/2026
TGTX TG Therapeutics	$49.90 +1.5%	8/4/2026	Emily Bodnar Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	$78.00	Buy	View details for HC Wainwright rating of TG Therapeutics (NASDAQ:TGTX) on 8/4/2026
FEAM 5E Advanced Materials	$1.84 -6.1%	8/4/2026	Heiko Ihle Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	$5.50 ➝ $3.50	Buy	View details for HC Wainwright rating of 5E Advanced Materials (NASDAQ:FEAM) on 8/4/2026
SPTX Seaport Therapeutics	$23.36 +1.5%	8/4/2026	Raghuram Selvaraju Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	$50.00	Buy	View details for HC Wainwright rating of Seaport Therapeutics (NASDAQ:SPTX) on 8/4/2026
WVE WAVE Life Sciences	$5.05 -16.8%	8/3/2026	Andrew S. Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating		Buy	View details for HC Wainwright rating of WAVE Life Sciences (NASDAQ:WVE) on 8/3/2026
MSTR Strategy	$96.09 -1.3%	8/3/2026	Mike Colonnese Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Set Price Target	$325.00		View details for HC Wainwright rating of Strategy (NASDAQ:MSTR) on 8/3/2026
ALMS Alumis	$25.37 -7.8%	8/3/2026	Mitchell S. Kapoor Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	$25.00	Neutral	View details for HC Wainwright rating of Alumis (NASDAQ:ALMS) on 8/3/2026
AUTL Autolus Therapeutics	$2.33 +12.6%	8/3/2026	Emily Bodnar Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	$10.00	Buy	View details for HC Wainwright rating of Autolus Therapeutics (NASDAQ:AUTL) on 8/3/2026
BLCO Bausch + Lomb	$16.85 +0.1%	8/3/2026	Yi Chen Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Price Target	$20.00 ➝ $21.00	Buy	View details for HC Wainwright rating of Bausch + Lomb (NYSE:BLCO) on 8/3/2026
DTIL Precision BioSciences	$7.51 +0.7%	8/3/2026	Patrick R. Trucchio Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating		Buy	View details for HC Wainwright rating of Precision BioSciences (NASDAQ:DTIL) on 8/3/2026
EVMN Evommune	$14.20 +0.9%	8/3/2026	Mitchell S. Kapoor Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating		Neutral	View details for HC Wainwright rating of Evommune (NYSE:EVMN) on 8/3/2026
LBRX LB Pharmaceuticals	$45.33 -1.1%	8/3/2026	Raghuram Selvaraju Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	$45.00	Buy	View details for HC Wainwright rating of LB Pharmaceuticals (NASDAQ:LBRX) on 8/3/2026
ORKA Oruka Therapeutics	$104.68 -0.4%	8/3/2026	Mitchell S. Kapoor Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	$120.00	Buy	View details for HC Wainwright rating of Oruka Therapeutics (NASDAQ:ORKA) on 8/3/2026
PGEN Precigen	$6.86 -2.0%	8/3/2026	Swayampakula Ramakanth Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	$14.00	Buy	View details for HC Wainwright rating of Precigen (NASDAQ:PGEN) on 8/3/2026
The $15 Gold Fund That Pays Up to $1,152/Month (Ad) Gold is hitting record highs, but most investors are leaving income on the table. A $15 fund is quietly paying out up to $1,152 a month to regular investors - no mining stocks, no options, no physical metal required. Chief Income Strategist Tim Plaehn calls it a breakthrough strategy that transforms gold's rally into reliable monthly payouts. The next distribution is just days away. Discover the gold income fund before the next payout date
TEM Tempus AI	$55.69 +1.1%	8/3/2026	Yi Chen Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Lower Price Target	$64.00 ➝ $56.00	Buy	View details for HC Wainwright rating of Tempus AI (NASDAQ:TEM) on 8/3/2026
WWR Westwater Resources	$0.60 -3.6%	8/3/2026	Heiko F. Ihle Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Lower Price Target	$1.75 ➝ $1.50	Buy	View details for HC Wainwright rating of Westwater Resources (NASDAQ:WWR) on 8/3/2026
MSTR Strategy	$96.09 -1.3%	7/31/2026		Reiterated Rating		Buy	View details for HC Wainwright rating of Strategy (NASDAQ:MSTR) on 7/31/2026
CDNA CareDx	$47.23 +0.3%	7/31/2026	Yi Chen Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	$46.00	Neutral	View details for HC Wainwright rating of CareDx (NASDAQ:CDNA) on 7/31/2026
PHAT Phathom Pharmaceuticals	$8.51 -0.7%	7/31/2026	Matthew Caufield Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	$26.00	Buy	View details for HC Wainwright rating of Phathom Pharmaceuticals (NASDAQ:PHAT) on 7/31/2026
IKT Inhibikase Therapeutics	$2.45 -0.4%	7/31/2026		Reiterated Rating	$8.00	Buy	View details for HC Wainwright rating of Inhibikase Therapeutics (NASDAQ:IKT) on 7/31/2026
MDGL Madrigal Pharmaceuticals	$535.27 +3.9%	7/31/2026	Andrew S. Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating		Buy	View details for HC Wainwright rating of Madrigal Pharmaceuticals (NASDAQ:MDGL) on 7/31/2026
ALNY Alnylam Pharmaceuticals	$221.20 +1.9%	7/31/2026	Patrick R. Trucchio Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Lower Price Target	$485.00 ➝ $455.00	Buy	View details for HC Wainwright rating of Alnylam Pharmaceuticals (NASDAQ:ALNY) on 7/31/2026
COIN Coinbase Global	$148.58 -0.1%	7/31/2026	Mike Colonnese Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	$265.00	Buy	View details for HC Wainwright rating of Coinbase Global (NASDAQ:COIN) on 7/31/2026
KPTI Karyopharm Therapeutics	$2.10 +7.1%	7/31/2026	Robert Burns Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Downgrade		Buy ➝ Negative	View details for HC Wainwright rating of Karyopharm Therapeutics (NASDAQ:KPTI) on 7/31/2026

MarketBeat Community Rating for HC Wainwright

MarketBeat's community ratings are surveys of what our community members think about HC Wainwright and other research firms in the last 90 days. Vote "Outperform" if you believe HC Wainwright's recommendations will outperform the broader market over the long term. Vote "Underperform" if you believe HC Wainwright's recommendations will underperform the broader market over the long term. You may vote once every thirty days.

Log in to vote on this brokerage.

COMMUNITY RATINGS: 0.0out of 5 (last 90 days)
0 of 5 stars
OUTPERFORM VOTES: 0 Believe will outperform the market
UNDERPERFORM VOTES: 0 Believe will underperform the market

Analysts at HC Wainwright

HC Wainwright's equity research team has issued ratings on 643 companies across 11 sectors over the past 12 months, covered by 36 analysts. The HC Wainwright analysts below are listed by number of ratings issued in the last year.

HC Wainwright Stock Coverage by Sector

HC Wainwright concentrates its research most heavily in Healthcare (73.9%), Technology (8.1%) and Materials (6.2%). The chart below shows how HC Wainwright's 644 rated companies are distributed across all 11 sectors it covers.

Healthcare
476 companies
73.9%
Technology
52 companies
8.1%
Materials
40 companies
6.2%
Industrials
36 companies
5.6%
Finance
15 companies
2.3%
Energy
11 companies
1.7%
Consumer Staples
4 companies
0.6%
Consumer Discretionary
3 companies
0.5%
Utilities
3 companies
0.5%
Communication Services
2 companies
0.3%
Real Estate
1 company
0.2%

Best & Worst Calls

Best Call
000000.0%
NASDAQ:NVAX
Initiated Coverage • Jan 22, 2020
Subscribe to MarketBeat All Access to get analyst recommendation ROI.
Worst Call
0000.0%
NASDAQ:EFTR
Reiterated Rating • Nov 14, 2023
Subscribe to MarketBeat All Access to get analyst recommendation ROI.

Similarly Rated Firms

HC Wainwright - Frequently Asked Questions

HC Wainwright's analysts currently have buy-equivalent ratings on 606 companies. Recent upgrades to buy include Prime Medicine, Zscaler and Circle Internet Group.

HC Wainwright's highest-rated analysts by MarketBeat's accuracy score include Raghuram Selvaraju, Andrew Fein and Mitchell Kapoor. Rankings are based on historical rating accuracy and price target precision over the past 12 months. MarketBeat tracks 36 analysts at HC Wainwright.

HC Wainwright has the deepest coverage in Healthcare (73.9% of rated companies), Technology (8.1% of rated companies), Materials (6.2% of rated companies), Industrials (5.6% of rated companies) and Finance (2.3% of rated companies).

HC Wainwright issued 2,088 ratings over the last 12 months across 644 companies â€” an average of roughly 174 rating actions per month. These include boost price target, downgrade, initiated coverage, lower price target, reiterated rating, set price target and upgrade. MarketBeat tracks every rating change as it's published so you can see the most current HC Wainwright analyst actions.

Stock Forecasts and Research Tools

Today's Analyst Ratings

Top-Rated Stocks

More Ratings Tools

Price Forecasts for Popular Stocks

Top Stock Recommendations by Brokerage

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?